KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Research & Development (2016 - 2026)

Cme has reported Research & Development over the past 18 years, most recently at $76.6 million for Q1 2026.

  • Quarterly Research & Development rose 16.59% to $76.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $294.1 million through Mar 2026, up 12.21% year-over-year, with the annual reading at $283.2 million for FY2025, 10.71% up from the prior year.
  • Research & Development was $76.6 million for Q1 2026 at Cme, up from $75.2 million in the prior quarter.
  • Over five years, Research & Development peaked at $76.6 million in Q1 2026 and troughed at $45.9 million in Q1 2022.
  • The 5-year median for Research & Development is $59.4 million (2024), against an average of $60.2 million.
  • Biggest five-year swings in Research & Development: decreased 6.9% in 2022 and later rose 20.26% in 2024.
  • Tracing CME's Research & Development over 5 years: stood at $50.0 million in 2022, then rose by 17.0% to $58.5 million in 2023, then rose by 12.31% to $65.7 million in 2024, then increased by 14.46% to $75.2 million in 2025, then grew by 1.86% to $76.6 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $76.6 million, $75.2 million, and $71.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.